Gunn SR.The vanguard has arrived in the clinical laboratory: array-based karyotyping for prognostic markers in CLL. J Mol Diagn 2010, (in press).

Yeh I-T, et al. Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event. Modern Pathology 2009, 22(9);1169-1175.

Gunn S, et al. Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia. Leukemia 2009, 23:1011-1017..

Gunn S, et al. (2008) Whole-genome scanning by array CGH as a clinical tool for risk assessment in chronic lymphocytic leukemia. Journal of Molecular Diagnostics 2008, 10:442–45.

Higgins RA, Gunn SR and Robetorye RS. Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia (2008) Molecular Diagnosis and Therapy, 12 (5): 271-280.

Shelly Gunn, et al. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity. BMC Cancer 2010, 10:396 (28 July 2010)

Chin SF et al. Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene. 2007 Mar 22; 26(13):1959-70.

Bergamaschi A et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer. 2006 Nov; 45(11):1033-40.

Kwei, et al. Molecular Oncology 2010.